Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies
Abstract
Knowledge of the contemporary epidemiology of hepatitis B virus (HBV) infection among military personnel can inform potential Department of Defense (DoD) screening policy and infection and disease control strategies.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 10, 2020
- Source ID
- 10.1093/milmed/usaa131
Entities
People
- Aatif M. Hayat
- Adam W. Armstrong
- Angelia A. Eick-cost
- Beth Blackwell
- Charmagne G. Beckett
- Clinton K. Murray
- David M. Brett-major
- Francisco J. Rentas
- Hala H. Maktabi
- Jason F. Okulicz
- Jason M. Blaylock
- Jennifer A. Malia
- Laura A. Pacha
- Linda L. Jagodzinski
- Michael A. Forgione
- Nelson Michael
- Paul T. Scott
- Peter Dawson
- Robert L. Cohen
- Roland L Fahie
- Sheila A. Peel
- Shilpa Hakre
- Stephen A. Harrison
- Steven B. Cersovsky
Organizations
- Defense Health Agency
- Emmes Corporation
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Naval Medical Research Center
- San Antonio Military Medical Center
- United States Agency for International Development
- United States Department of Defense
- Walter Reed Army Institute of Research
- Walter Reed National Military Medical Center